Therapeutic Group: Gynaecological Presentation RehanzilTM : Each Tablet contains Relugolix INN 40 mg, Estradiol BP 1 mg & Norethindrone Acetate USP 0.5 mg. Description Rehanzil is a combination of Relugolix, Estradiol (E2), and Norethindrone Acetate (NETA). Relugolix is a non-peptide GnRH receptor antagonist that competitively binds to pituitary GnRH receptors, thereby reducing the release of […]